SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 38,452.00 |
| Book Value / Share | n/a |
| Price / Book | n/a |
| NCAV ($M) | -36,381.00 |
| NCAV / Share | n/a |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.17 |
| Return on Assets (ROA) | 0.14 |
| Return on Equity (ROE) | 0.32 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.61 |
| Current Ratio | 0.79 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 25,108.00 |
| Assets | 99,941.00 |
| Liabilities | 61,489.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 51,722.00 |
| Operating Income | 16,320.00 |
| Net Income | 11,941.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 17,619.00 |
| Cash from Investing | -7,513.00 |
| Cash from Financing | -11,742.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 338,808 | 1,545,388 | 21.92 | |
| 249,716 | 1,338,510 | 18.66 | |
| 406,389 | 2,056,219 | 19.76 | |
| 206,460 | 1,080,042 | 19.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABBV – AbbVie Inc. | ABT – Abbott Laboratories |
| ADCT – ADC Therapeutics SA | ANRO – Alto Neuroscience, Inc. |
| ANVS – Annovis Bio, Inc. |
Financial data and stock pages provided by
Fintel.io